Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pretax income is the income that a company earns before paying income taxes. Edwards Lifesciences's pretax income for the
three
months ended in Jun. 2026 was €451 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Jun. 2026 was €1,222 Mil.
Edwards Lifesciences's pretax margin was 29.86%.
During the past 13 years, Edwards Lifesciences's highest Pretax Margin was 34.04%. The lowest was 20.45%. And the median was 27.11%.
During the past 13 years, Edwards Lifesciences's highest Pretax Margin was 34.04%. The lowest was 20.45%. And the median was 27.11%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Edwards Lifesciences Pre-Tax Income Related Terms
Edwards Lifesciences Pre-Tax Income Historical Data
* Premium members only.
The historical data trend for Edwards Lifesciences's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:EWLS vs BSX, DXCM, GEHC: Pre-Tax Income Comparison
For the Medical Devices subindustry, Edwards Lifesciences's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Edwards Lifesciences Pre-Tax Income vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Edwards Lifesciences's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,222 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Edwards Lifesciences (WBO:EWLS) has a Pre-Tax Income of €1,222 Mil as of Jun. 2026. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Edwards Lifesciences and its competitors.
Is Edwards Lifesciences' Pre-Tax Income too high?
Edwards Lifesciences' current Pre-Tax Income is €1,222 Mil. Overall, Edwards Lifesciences has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Edwards Lifesciences' Pre-Tax Income compare to BSX and DXCM?
Edwards Lifesciences' Pre-Tax Income of €1,222 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Medical Devices & Instruments company?
A good Pre-Tax Income depends on the Medical Devices & Instruments industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Edwards Lifesciences and its competitors. Edwards Lifesciences's current Pre-Tax Income is €1,222 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edwards Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Edwards Lifesciences (WBO:EWLS) is currently considered Fairly Valued. The stock's GF Value™ is €81.45, compared to a current price of €74.46 — trading 8.6% below its estimated fair value. The current Pre-Tax Income is €1,222 Mil. Edwards Lifesciences' overall GF Score™ is 96/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For Edwards Lifesciences (WBO:EWLS), the current Pre-Tax Income is €1,222 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Edwards Lifesciences (WBO:EWLS) Overvalued in 2026?
Based on GuruFocus' analysis, Edwards Lifesciences stock appears to be undervalued.
The current stock price of €74.46 is trading 8.6% below its estimated GF Value™ of €81.45.
GuruFocus considers Edwards Lifesciences to be Fairly Valued.
Key valuation signals for WBO:EWLS:
Pre-Tax Income: €1,222 Mil
GF Value™: €81.45 vs. price of €74.46 (8.6% below fair value)
No single metric tells the full story. See the WBO:EWLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
96GF Score
Get the complete analysis for WBO:EWLS
Pre-Tax Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:EWLS has been successfully added to your 
